VICINI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 1.469
EU - Europa 1.293
AS - Asia 306
SA - Sud America 13
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.091
Nazione #
US - Stati Uniti d'America 1.461
IT - Italia 495
GB - Regno Unito 350
IE - Irlanda 135
CN - Cina 116
SE - Svezia 90
DE - Germania 74
SG - Singapore 65
HK - Hong Kong 52
UA - Ucraina 34
FI - Finlandia 25
FR - Francia 20
IN - India 17
BG - Bulgaria 15
ID - Indonesia 15
BE - Belgio 11
TR - Turchia 11
LT - Lituania 10
MK - Macedonia 9
PH - Filippine 8
BR - Brasile 6
GR - Grecia 6
CA - Canada 5
VN - Vietnam 5
CH - Svizzera 4
KR - Corea 4
MY - Malesia 4
NG - Nigeria 4
AR - Argentina 3
CL - Cile 3
ES - Italia 3
MX - Messico 3
AL - Albania 2
BD - Bangladesh 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
IR - Iran 2
JP - Giappone 2
LY - Libia 2
PL - Polonia 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AT - Austria 1
AU - Australia 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
NL - Olanda 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
Totale 3.091
Città #
Southend 303
Fairfield 184
Chandler 164
Dublin 134
Ashburn 124
Ann Arbor 103
Woodbridge 103
Nyköping 77
Seattle 75
Houston 72
Wilmington 69
Dearborn 62
Jacksonville 60
Cambridge 57
Hong Kong 51
Singapore 50
Modena 46
Bologna 36
Milan 34
Beijing 30
New York 26
San Diego 25
Rome 24
Reggio Emilia 20
Bremen 18
Eugene 16
Princeton 16
Helsinki 15
Jakarta 15
Sofia 15
Shanghai 14
Brussels 11
Redwood City 11
Izmir 9
Falls Church 8
Florence 8
Frankfurt am Main 8
Parma 8
Fulham 6
Bari 5
Boardman 5
Dallas 5
Fremont 5
Lappeenranta 5
London 5
Los Angeles 5
Palermo 5
Paris 5
Perugia 5
Roggiano Gravina 5
Turin 5
Brescia 4
Des Moines 4
Dong Ket 4
Lagos 4
Munich 4
Norwalk 4
Padova 4
Piacenza 4
Skopje 4
Alzate Brianza 3
Augusta 3
Bagnacavallo 3
Cagliari 3
Catania 3
Chios 3
Comun Nuovo 3
Formigine 3
Grafing 3
Guarene 3
Kunming 3
Martano 3
Mexicali 3
Monmouth Junction 3
Mumbai 3
Sassari 3
Shenyang 3
Shenzhen 3
Albignasego 2
Andover 2
Arcore 2
Arezzo 2
Avellino 2
Bagnoli del Trigno 2
Boston 2
Bra 2
Bregnano 2
Buenos Aires 2
Chania 2
Chicago 2
Cisternino 2
Civita Castellana 2
Colle Umberto 2
Forlì 2
Gangnam-gu 2
Guastalla 2
Hackney 2
Hangzhou 2
Hefei 2
Ivrea 2
Totale 2.301
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 351
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 301
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 262
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 243
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 242
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 176
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 160
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study 154
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 136
Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial 136
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 132
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 127
Biomarker expression and survival after primary chemotherapy for breast cancer. 112
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 105
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 103
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 94
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 84
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 64
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 42
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 31
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 28
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 24
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 16
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 13
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 7
Totale 3.143
Categoria #
all - tutte 13.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020375 0 0 0 13 53 68 88 38 37 19 25 34
2020/2021527 42 25 71 30 57 20 44 46 45 84 48 15
2021/2022389 17 31 26 12 10 26 16 31 51 23 103 43
2022/2023651 53 61 40 46 57 62 16 50 195 12 27 32
2023/2024577 31 26 33 57 54 54 63 73 36 46 51 53
2024/2025143 37 25 45 36 0 0 0 0 0 0 0 0
Totale 3.143